Recent Finacing
Recent Raise
Tarveda Therapeutics develops Pentarins—miniaturized biologic drug conjugates engineered for deep tumor penetration and targeted payload delivery; pipeline includes SSTR2-targeting PEN-221 and HSP90-targeting PEN-866.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
